What’s Up And Coming At Revolo Biotherapeutics?

Revolo’s plans for 2025 include expanding clinical trials for its lead eosinophilic esophagitis candidate and developing a sublingual delivery method.
An excerpt from "Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D." - check out the full video at www.bioprocess...
---
#businessofbiotech #biopharma #biotech
Subscribe to the podcast:
Apple - podcasts.apple...
Spotify - open.spotify.c...
RUclips - • The Business Of Biotec...